172@29@17@151!~!172@29@0@53!~!|news|india|tradeindia-to-organise-countrys-first-3-day-virtual-trade-show-for-msmes-5501181.html?utm_source=MC_OpeninApp!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Jul 02, 2020 09:39 PM IST | Source: PTI

TradeIndia to organise country's first 3-day virtual trade show for MSMEs

The event is targeted to revive various micro, small and medium enterprises (MSMEs), whose operations have been affected due to the coronavirus crisis, and help them maintain business continuity in such uncertain times, it added.

PTI
representative image
representative image

TradeIndia, a business-to- business (B2B) marketplace that offers global buyers and sellers a platform to identify business partners, on Thursday said it will organise the country's first virtual three-day trade show, 'COVID-19 Essentials Expo India', from August 5.

The trade expo will be on the lines of a traditional exhibition, but will be conducted via virtual medium due to the COVID-19 pandemic concerns, TradeIndia said in a statement.

The event is targeted to revive various micro, small and medium enterprises (MSMEs), whose operations have been affected due to the coronavirus crisis, and help them maintain business continuity in such uncertain times, it added.

Close

The expo also aims to discover alternate channels of revenue for companies that are suitable for the current market dynamics.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The trade show will also feature 3D stalls or immersive virtual spaces that enable attendees to sift through various product line-ups, access business catalogues while interacting with exhibitors via chat or video conference.

While the pandemic has wreaked havoc upon industries and economy, it has also opened up hitherto unlocked vistas of promising opportunities as businesses across the world are united in their transition from offline mode to online mode, a TradeIndia spokesperson said.

"We strive to tap into the exuberant potential of the digital business model and also extend a much needed lift up to the struggling factions of SMEs and MSMEs and help them shift to online medium for commencing business through this first of its kind landmark virtual tradeshow," he added.

Follow our full coverage of the coronavirus pandemic here.
First Published on Jul 2, 2020 09:30 pm
Sections